← Back to Search

Acceptance and Commitment Therapy for Chronic Pain

N/A

Waitlist Available

Led By Elissa Kolva, PhD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from baseline to end of intervention (weeks 1- 8)

Awards & highlights

Study Summary

This trial will help cancer survivors manage chronic pain through Acceptance and Commitment Therapy (ACT) after active cancer treatment.

Who is the study for?

This trial is for cancer survivors aged 18-100 who've been out of active treatment for at least three months, speak English, and are mentally stable. They should have had solid tumor cancers, be free of or have stable chronic disease, and experience moderate to severe pain from their cancer that's lasted over three months.Check my eligibility

What is being tested?

The study tests Acceptance and Commitment Therapy (ACT) as a way to manage chronic pain in cancer survivors against the usual treatments they receive. Participants will either receive ACT sessions or continue with their regular care to see which helps more with pain.See study design

What are the potential side effects?

Since ACT involves therapy rather than medication, side effects aren't like those from drugs but may include emotional discomfort or distress due to discussing painful experiences during the therapeutic process.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from baseline to end of intervention (weeks 1- 8)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from baseline to end of intervention (weeks 1- 8)

This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to end of intervention (weeks 1- 8) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The Degree of Effectiveness of Acceptance and Commitment Therapy: [Impact]

Secondary outcome measures

Number of Participants Who Want to Use Acceptance and Commitment Therapy as a Method for Treating Chronic Pain Post Active Cancer Treatment Active Cancer Treatment

The Ability of Methodological Strategies Used to Monitor and Enhance the Reliability and Validity of ACT: [Fidelity]

The Degree to Which Patients Enjoy Using Acceptance and Commitment Therapy as a Method for Treating Chronic Pain Post Active Cancer Treatment: [Acceptability]

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Acceptance and Commitment TherapyExperimental Treatment1 Intervention

Participants will receive both the ACT intervention and medication management that is given as usual treatment.

Group II: Treatment as UsualActive Control1 Intervention

Treatment as usual will include ongoing provision of usual treatment options for pain management.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Acceptance and Commitment Therapy

2010

Completed Phase 1

~1490

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,732 Previous Clinical Trials

2,143,533 Total Patients Enrolled

6 Trials studying Chronic Pain

597 Patients Enrolled for Chronic Pain

Elissa Kolva, PhDPrincipal InvestigatorUniversity of Colorado, Denver

1 Previous Clinical Trials

Media Library

Acceptance and Commitment Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03661840 — N/A

Chronic Pain Research Study Groups: Acceptance and Commitment Therapy, Treatment as Usual

Chronic Pain Clinical Trial 2023: Acceptance and Commitment Therapy Highlights & Side Effects. Trial Name: NCT03661840 — N/A

Acceptance and Commitment Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03661840 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research project open to new participants?

"Unfortunately, this clinical trial is not accepting new participants at the moment. It was originally posted on December 4th 2018 and edited for the last time on February 14th 2022. Though one cannot take part in this study currently, there are 403 other trials that require participants now."

Answered by AI

Are elderly adults eligible for this trial?

"According to the trial requirements, suitable candidates for this medical study must be between 18 and 100 years of age. Notably, there are 33 trials targeting minors and 362 offering treatments specifically tailored towards seniors."

Answered by AI

Am I eligible to take part in this research initiative?

"This clinical trial is recruiting 50 patients aged 18-100 who have chronically experienced pain due to their cancer. To be eligible for enrollment, participants must satisfy the following criteria: registering at least 4 points on the Chronic pain Grading Questionnaire's "Pain Interference" item; signing and dating a consent form; agreeing to comply with all study procedures over its duration; having had pathology confirmed diagnosis of solid tumour cancer three or more months prior; being in remission from active treatment (surgery, chemotherapy, radiation); suffering chronic pain for three or more months beforehand without signs of NED/stable disease under watchful waiting; fluent English speakers"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors

2018. "Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03661840.

All > American Chronic Pain > Chronic Pain